TNKase is administered as a single intravenous bolus over 5 seconds. The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in ...

Study Will Investigate Pegevongitide's Ability to Prevent Acute Brain Injury in the Uniquely Vulnerable Hemodialysis Patient ...

An earlier start to anticoagulation after an acute ischemic stroke for patients found to have atrial fibrillation appeared safe and possibly improved outcomes, according to the randomized ELAN trial.

Please provide your email address to receive an email when new articles are posted on . Researchers engaged in a secondary analysis of the ESCAPE clinical trial in patients with acute ischemic stroke.

A clinical decision support tool that uses artificial intelligence (AI) to analyze scans after a stroke alongside treatment ...

Key points A 68-year-old woman presented to the emergency department of a rural hospital in southern Alberta 1 hour after ...

A new analysis supports the use of intravenous (IV) tenecteplase over IV alteplase (tissue plasminogen activator) for treatment of acute ischemic stroke. The analysis found that patients with ischemic ...

Please provide your email address to receive an email when new articles are posted on . TNKase is the first stroke treatment approved by the FDA in almost 30 years, the manufacturer said. It is ...

In a randomized, sham-controlled study published in the Journal of the American Medical Association (JAMA), researchers investigated the effect of remote ischemic conditioning (RIC) on functional ...

Noncontrast CT is commonly used to diagnose acute stroke because of its ability to detect acute hemorrhage, although it is less sensitive for early detection of ischemic stroke. The American Academy ...